View in EDS HTML Full Text PDF Full Text

CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.

Saved in:

Bibliographic Details
Title:	CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.
Authors:	Hsu, Andrew^1,2 (AUTHOR), Kurt, Habibe³ (AUTHOR), Zayac, Adam S.¹ (AUTHOR), Olszewski, Adam J.^1,2 (AUTHOR)
Source:	Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p31-42. 12p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	10428194
DOI:	10.1080/10428194.2021.1973670